Winslow Evans & Crocker Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$481K |
| 2 |
PayPal
PYPL
|
+$408K |
| 3 |
McDonald's
MCD
|
+$384K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$382K |
| 5 |
SINA
Sina Corp
SINA
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.03M |
| 2 |
Apple
AAPL
|
+$1.82M |
| 3 |
Automatic Data Processing
ADP
|
+$1.33M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.28M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Healthcare | 12.61% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Energy | 8.16% |
Similar funds
Winslow Evans & Crocker's Q3 2017 Portfolio in Review
As of Q3 2017, Winslow Evans & Crocker held 1,314 positions worth $302M, down 17% from $365M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Winslow Evans & Crocker withdrew a net $78M in Q3 2017, closing 197 positions and reducing 571 holdings. Its most notable exit was Veeva Systems, an estimated $619K position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Winslow Evans & Crocker opened a new position in Regeneron Pharmaceuticals worth $358K.
- Winslow Evans & Crocker's largest Q3 2017 buy was Regeneron Pharmaceuticals: 802 shares worth $358K.
- Winslow Evans & Crocker added most to Deere & Co in Q3 2017, an estimated $481K increase.
- Winslow Evans & Crocker's biggest Q3 2017 reduction was Microsoft, cutting an estimated $2.03M.
- Winslow Evans & Crocker fully exited Veeva Systems in Q3 2017, selling an estimated $619K.
- Winslow Evans & Crocker's ten largest holdings make up 22% of its $302M portfolio in Q3 2017.
- Winslow Evans & Crocker opened 44 new positions and closed 197 in Q3 2017.
- Winslow Evans & Crocker's portfolio value fell 17% quarter-over-quarter to $302M.
Based on Winslow Evans & Crocker's 13F filing for Q3 2017, filed 19 Oct 2017.